POLQ and systemic lupus erythematosus: The observed marrow suppression in conditions such as SLE, coupled with corresponding autoantibodies, accentuates the prospective cross-reactivity of these autoantibodies against other pivotal targets, possibly including the DNA polymerase theta [30, 31].